Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease.
A simple blood test could detect Alzheimer’s disease with 100% accuracy, according to research from Resonant, a Utah biotech ...
Medicare will cover new class of Alzheimer's drugs if fully approved by FDA, with limits Jun 2, 2023 The real costs of the new Alzheimer's drug, most of which will fall to taxpayers Aug 14, 2023 ...
BLUFFTON, S.C. (WCSC) - One of the first Alzheimer’s patients in the Lowcountry to take part in Leqembi infusion treatments ...
Plasma phosphorylated tau 217 (p-tau217) outperformed p-tau181, p-tau231, and other blood-based biomarkers to identify which ...
The EU recommends Anavex proceed with a full approval application for Alzheimer's drug Blarcamesine based on full Phase 2b/3 trial data. The U.S. FDA may grant accelerated approval to Anavex's ...
A Saint Louis University researcher was instrumental in developing the first and only Food and Drug Administration (FDA) approved treatment for agitation associated with Alzheimer's dementia.
Since the FDA’s approval of lecanemab (marketed as Leqembi) and Medicare’s recent decision to cover the drug, I have met with Alzheimer’s patients and their loved ones who are anxious to ...
New treatments and tests for dementia are finally here, after decades of disappointments The post Dementia Breakthroughs ...
A small pharmaceutical company in Research Triangle Park is considering its next steps after seeing positive results in a clinical study evaluating its treatment for Alzheimer's disease.
American mortality is at the youngest it has been in almost two decades. But could repurposing a decades-old diabetes drug ...
WASHINGTON, Dec. 5, 2023 /PRNewswire/ -- The FDA agreed to require important American Academy of Dermatology's (AAD) recommended changes to the iPLEDGE program that will alleviate administrative ...
